Literature DB >> 11779911

Predictors of cognitive dysfunction after subarachnoid hemorrhage.

Kurt T Kreiter, Daphne Copeland, Gary L Bernardini, Joseph E Bates, Shelley Peery, Jan Claassen, Y Evelyn Du, Yaakov Stern, E Sander Connolly, Stephan A Mayer.   

Abstract

BACKGROUND: Cognitive dysfunction is a common and disabling sequela of subarachnoid hemorrhage (SAH). Although several clinical and radiographic findings have been implicated in the pathogenesis of cognitive dysfunction after SAH, few prospective studies have comprehensively and simultaneously evaluated these risk factors.
METHODS: Between July 1996 and March 2000, we prospectively evaluated 113 of 248 consecutively admitted nontraumatic SAH patients alive at 3 months with a comprehensive neuropsychological evaluation. Summary scores for 8 cognitive domains were calculated to express test performance relative to the entire study population. Clinical and radiographic variables associated with domain-specific cognitive dysfunction were identified with forward stepwise multiple regression, with control for the influence of demographic factors.
RESULTS: The study participants were younger (P=0.005), less often white (P=0.006), and had better 3-month modified Rankin scores (P=0.001) than those who did not undergo neuropsychological testing. The proportion of subjects who scored in the impaired range (>2 SD below the normative mean) on each neuropsychological test ranged from 10% to 50%. Predictors of cognitive dysfunction in 2 or more domains in the multivariate analysis included global cerebral edema (4 domains), left-sided infarction (3 domains), and lack of a posterior circulation aneurysm (2 domains). Other variables consistently associated with cognitive dysfunction in the univariate analysis included admission Hunt-Hess grade >2 and thick SAH in the anterior interhemispheric and sylvian fissures.
CONCLUSIONS: Global cerebral edema and left-sided infarction are important risk factors for cognitive dysfunction after SAH. Treatment strategies aimed at reducing neurological injury related to generalized brain swelling, infarction, and clot-related hemotoxicity hold the best promise for improving cognitive outcomes after SAH.

Entities:  

Mesh:

Year:  2002        PMID: 11779911     DOI: 10.1161/hs0102.101080

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  83 in total

1.  Intensive care unit management of aneurysmal subarachnoid hemorrhage.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

2.  Brain hemorrhage: assessing outcome after subarachnoid hemorrhage.

Authors:  Tom A Schweizer; R Loch Macdonald
Journal:  Nat Rev Neurol       Date:  2010-08       Impact factor: 42.937

3.  Long-term cognitive deficits in patients with good outcomes after aneurysmal subarachnoid hemorrhage from anterior communicating artery.

Authors:  Janez Ravnik; Barbara Starovasnik; Sanja Sesok; Zvezdan Pirtosek; Viktor Svigelj; Gorazd Bunc; Roman Bosnjak
Journal:  Croat Med J       Date:  2006-04       Impact factor: 1.351

4.  Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage.

Authors:  Jan Claassen; Lawrence J Hirsch; Jennifer A Frontera; Andres Fernandez; Michael Schmidt; Gregory Kapinos; John Wittman; E Sander Connolly; Ronald G Emerson; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

5.  Minocycline improves functional outcomes, memory deficits, and histopathology after endovascular perforation-induced subarachnoid hemorrhage in rats.

Authors:  Prativa Sherchan; Tim Lekic; Hidenori Suzuki; Yu Hasegawa; William Rolland; Kamil Duris; Yan Zhan; Jiping Tang; John H Zhang
Journal:  J Neurotrauma       Date:  2011-10-20       Impact factor: 5.269

Review 6.  SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.

Authors:  R Loch Macdonald; Blessing Jaja; Michael D Cusimano; Nima Etminan; Daniel Hanggi; David Hasan; Don Ilodigwe; Hector Lantigua; Peter Le Roux; Benjamin Lo; Ada Louffat-Olivares; Stephan Mayer; Andrew Molyneux; Audrey Quinn; Tom A Schweizer; Thomas Schenk; Julian Spears; Michael Todd; James Torner; Mervyn D I Vergouwen; George K C Wong; Jeff Singh
Journal:  Transl Stroke Res       Date:  2013-01-07       Impact factor: 6.829

7.  Intracisternal administration of tissue plasminogen activator improves cerebrospinal fluid flow and cortical perfusion after subarachnoid hemorrhage in mice.

Authors:  Dominic A Siler; Jorge A Gonzalez; Ruikang K Wang; Justin S Cetas; Nabil J Alkayed
Journal:  Transl Stroke Res       Date:  2014-02-14       Impact factor: 6.829

8.  Cerebral inflammatory response and predictors of admission clinical grade after aneurysmal subarachnoid hemorrhage.

Authors:  Khalid A Hanafy; R Morgan Stuart; Luis Fernandez; J Michael Schmidt; Jan Claassen; Kiwon Lee; E Sander Connolly; Stephan A Mayer; Neeraj Badjatia
Journal:  J Clin Neurosci       Date:  2009-12-08       Impact factor: 1.961

9.  Predictors for cognitive impairment one year after surgery for aneurysmal subarachnoid hemorrhage.

Authors:  M Orbo; K Waterloo; A Egge; J Isaksen; T Ingebrigtsen; B Romner
Journal:  J Neurol       Date:  2008-10-07       Impact factor: 4.849

10.  Endovascular perforation subarachnoid hemorrhage fails to cause Morris water maze deficits in the mouse.

Authors:  Eric Milner; Jacob C Holtzman; Stuart Friess; Richard E Hartman; David L Brody; Byung H Han; Gregory J Zipfel
Journal:  J Cereb Blood Flow Metab       Date:  2014-06-18       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.